Gestational age and maternal weight effects on fetal cell-free DNA in maternal plasma. - Wikidata - wikimedia - TriplyDB

Gestational age and maternal weight effects on fetal cell-free DNA in maternal plasma.

Gestational age and maternal weight effects on fetal cell-free DNA in maternal plasma.

http://www.wikidata.org/entity/Q34336915

about

Non-invasive prenatal testing for fetal chromosome abnormalities: review of clinical and ethical issues Non-Invasive Prenatal Testing Using Cell Free DNA in Maternal Plasma: Recent Developments and Future Prospects Review: cell-free fetal DNA in the maternal circulation as an indication of placental health and disease Limitations of Aneuploidy and Anomaly Detection in the Obese Patient.Repeated failed non-invasive prenatal testing in a woman with immune thrombocytopenia and antiphospholipid syndrome: lessons learnt.Probabilistic method for detecting copy number variation in a fetal genome using maternal plasma sequencing.Cell-free DNA release by mouse placental explants Quantification of cell-free DNA in normal and complicated pregnancies: overcoming biological and technical issues Diagnostic accuracy of routine antenatal determination of fetal RHD status across gestation: population based cohort study.Noninvasive prenatal screening for fetal aneuploidy, 2016 update: a position statement of the American College of Medical Genetics and Genomics.Performance of non-invasive prenatal testing when fetal cell-free DNA is absent.High-resolution characterization of sequence signatures due to non-random cleavage of cell-free DNA.A Cost-Effectiveness Analysis of First Trimester Non-Invasive Prenatal Screening for Fetal Trisomies in the United States Unexplained False Negative Results in Noninvasive Prenatal Testing: Two Cases Involving Trisomies 13 and 18.Comparison of two high-throughput semiconductor chip sequencing platforms in noninvasive prenatal testing for Down syndrome in early pregnancy Performance of Momguard, a new non-invasive prenatal testing protocol developed in Korea.An adaptive detection method for fetal chromosomal aneuploidy using cell-free DNA from 447 Korean women.Non-invasive prenatal testing for aneuploidy and beyond: challenges of responsible innovation in prenatal screening.Effects of sample processing and storage on the integrity of cell-free miRNAs in maternal plasma.Trophoblast retrieval and isolation from the cervix (TRIC) is unaffected by early gestational age or maternal obesity.Integration of noninvasive DNA testing for aneuploidy into prenatal care: what has happened since the rubber met the road?Report on noninvasive prenatal testing: classical and alternative approaches.Size-selective separation and overall-amplification of cell-free fetal DNA fragments using PCR-based enrichment.Non-invasive prenatal testing for aneuploidy: current status and future prospects.A single center's experience with noninvasive prenatal testing.Non-invasive prenatal diagnosis: progress and potential.Implementation of whole genome massively parallel sequencing for noninvasive prenatal testing in laboratories.Initial experience with non-invasive prenatal testing of cell-free DNA for major chromosomal anomalies in a clinical setting.Cell-Free Fetal DNA, Telomeres, and the Spontaneous Onset of Parturition.Noninvasive Antenatal Determination of Fetal Blood Group Using Next-Generation Sequencing.Prenatal DNA Sequencing: Clinical, Counseling, and Diagnostic Laboratory Considerations.Fetal aneuploidy screening with cell-free DNA in late gestation.Fetal genome profiling at 5 weeks of gestation after noninvasive isolation of trophoblast cells from the endocervical canal.Discordant non-invasive prenatal testing (NIPT) - a systematic review.The association between anticoagulation therapy, maternal characteristics, and a failed cfDNA test due to a low fetal fraction.Effects of Maternal and Fetal Characteristics on Cell-Free Fetal DNA Fraction in Maternal Plasma.Recommended practice for laboratory reporting of non-invasive prenatal testing of trisomies 13, 18 and 21: a consensus opinion.Position statement from the Chromosome Abnormality Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis.Haplotype-based approach for noninvasive prenatal tests of Duchenne muscular dystrophy using cell-free fetal DNA in maternal plasma.Fetal and Placental DNA Stimulation of TLR9: A Mechanism Possibly Contributing to the Pro-inflammatory Events During Parturition.

P2860

Q26764809-A7849DB7-A826-456D-8180-51DF42D1D970 Q26827338-D7468971-E08E-4509-A1D7-E6A9F2D9B4E6 Q26991553-04E6AF13-D7B7-4417-AD73-0C947F207540 Q30406201-C2A8FAF2-8290-42F9-B598-C73A72A16B15 Q33437396-AD9772AD-B7F6-49D6-83F7-CCD32F86AFDA Q33760408-BD26141F-0942-43EF-8DCE-D3C00802BD72 Q33806881-57941388-3A1A-41E7-8D29-78F133F83D58 Q33838434-2770DF1F-313E-407B-BB6E-B7016DC53E49 Q34132783-53BAB7FB-FD52-4A2D-8BEC-F02F25F486C3 Q34535626-5C76CA67-32CC-4616-B07B-F9626E96381F Q34996829-F9FDCEDF-DEE3-48A1-838D-72242ADA1479 Q35665317-C3FF5AD7-308F-488E-98D3-704AE2FB0E5B Q35680437-87B938DD-8A7E-415D-99A2-37425768F091 Q35763064-639FC96A-F81D-4B96-8049-48962622B980 Q36003623-F513CDAD-9B3A-42E0-8963-53FFAC9A915E Q36107557-1326FE97-9D1B-46ED-A4F2-6C0A60CC2B54 Q36157384-8AC6CACA-F452-4BAC-B51F-6695C5BEB836 Q36184534-36068D1F-A402-4403-9EEA-3FF379CAEC93 Q36384651-4844EEFA-604C-47A7-A67D-0CDBBCC245FF Q36469631-86F94233-F1EF-4EEB-A207-BE28E07033A7 Q36787475-B7028AD6-40D5-4581-8192-923A9A24A883 Q37320217-AE0C6E5E-35F4-4699-854A-3DC6D898F704 Q37593355-B2418DB2-72CF-4AF6-923A-BC90CCCA2829 Q38114375-A61140CE-D28C-4423-AF23-5053C4B501C7 Q38199941-E52BABA9-450D-484C-A64B-74E59CC1FEC9 Q38208530-0E0EC24E-9A80-4E75-BCAF-2F40FE3A4242 Q38262952-2497BF6D-3F51-48D7-B9DF-151A633A883B Q38419642-FC6D423C-EFEA-4F44-AF04-3E9C82449D0F Q38541725-DD999DF0-95CF-40BA-9DEC-6BDBD74E41F2 Q38618865-405D6271-BD3E-4E44-AF01-6B5A905032D3 Q38739393-55B46E6B-AEFC-434E-B4E3-33B374C6EBF8 Q38819938-A2C436B8-3E0B-4E79-BEFB-0E91E1D077C9 Q39222463-EA605C28-7E26-4B14-B577-127706AC19A0 Q39223783-61FC249D-AD53-4A18-888E-AAADB9A9FFF3 Q40053685-983E0318-09F2-4328-B1E8-B81806FEBFB2 Q40950309-27D00C53-E267-49D2-8B34-26B374E9C153 Q41113357-EA523467-CB9D-4C2A-803A-874196FBF0F4 Q41235376-18E17084-FC9E-4F5A-B0E0-825B990C8C45 Q41475376-BCA85D17-CC3F-446F-9B4A-792BC4993017 Q41912007-97BCA177-F340-477D-BCE1-3363B5839C4C

P2860

Gestational age and maternal weight effects on fetal cell-free DNA in maternal plasma.

http://www.wikidata.org/entity/Q34336915

description

2013 nî lūn-bûn

@nan

2013 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Gestational age and maternal weight effects on fetal cell-free DNA in maternal plasma.

@ast

Gestational age and maternal weight effects on fetal cell-free DNA in maternal plasma.

@en

Gestational age and maternal weight effects on fetal cell-free DNA in maternal plasma.

@nl

type

label

Gestational age and maternal weight effects on fetal cell-free DNA in maternal plasma.

@ast

Gestational age and maternal weight effects on fetal cell-free DNA in maternal plasma.

@en

Gestational age and maternal weight effects on fetal cell-free DNA in maternal plasma.

@nl

prefLabel

Gestational age and maternal weight effects on fetal cell-free DNA in maternal plasma.

@ast

Gestational age and maternal weight effects on fetal cell-free DNA in maternal plasma.

@en

Gestational age and maternal weight effects on fetal cell-free DNA in maternal plasma.

@nl

P1433

Q34336915-C847729B-A5F3-4519-A280-793DF78F3277

P1476

Q34336915-740F0A5A-D7CB-4553-901C-B6AE25BA0C6B

P2093

Q34336915-414E6E1C-ED4F-4763-A5D2-1003310534FA

Q34336915-41C0B356-76F3-4500-841E-EF8E0F025907

Q34336915-43C546D3-8D47-40B5-9772-3C310F65AB96

Q34336915-580B30C8-D49A-457B-9576-614566A181E5

Q34336915-77E4178C-9101-49D5-BE44-23707A12472B

Q34336915-ACE180F1-4450-41C5-9402-15BD632C4A9E

P2860

Q34336915-0D77AC2F-F1C0-4CBA-A44F-72E22B821BF7

Q34336915-16D1C73A-8BC4-410E-8591-467D1C4F84D7

Q34336915-47CDFE7F-E52A-4AB1-B14B-5F943F68C3A3

Q34336915-56CF7A5A-7F47-4FB4-A367-835BD035C65F

Q34336915-5A91DD61-5331-44E0-AAF5-5891F994E5F7

Q34336915-5B798861-916B-42BF-AE85-E0CD09AD1955

Q34336915-677379B7-543D-44C7-9509-73E2AAB52EA2

Q34336915-71B06BF8-16A0-45AF-AB85-6F3472D8BBC1

Q34336915-94349F83-69C1-4490-93AE-36FF54456236

Q34336915-9911AC93-F0E7-44D1-B219-3A2D3723670D

P304

Q34336915-B30C73CE-CED2-4E3D-B470-BE9E7F5A27FF

P31

Q34336915-0A8945C9-075D-4634-B51E-3611878831A8

P356

Q34336915-77249678-D3B8-417F-B3DF-FA8780A52F16

P433

Q34336915-2A2B5AFE-C86F-486C-A275-A99F799106BE

P478

Q34336915-6F331BA7-FC59-470B-9867-B69BCB64B693

P577

Q34336915-CED45719-A6CE-4158-A6A2-136BC471EBE5

P5875

Q34336915-812FEBB3-4A35-45BE-8212-4ADFB8F9B829

P698

Q34336915-EFF50BA8-3FB8-4EB6-AD7D-EC121C745268

P356

P1433

Prenatal Diagnosis

P1476

Gestational age and maternal weight effects on fetal cell-free DNA in maternal plasma.

@en

P2093

Annette Batey

http://www.w3.org/2001/XMLSchema#string

Arnold Oliphant

http://www.w3.org/2001/XMLSchema#string

Craig Struble

http://www.w3.org/2001/XMLSchema#string

Eric Wang

http://www.w3.org/2001/XMLSchema#string

Ken Song

http://www.w3.org/2001/XMLSchema#string

Thomas Musci

http://www.w3.org/2001/XMLSchema#string

P2860

ACOG Practice Bulletin No. 77: Screening for Fetal Chromosomal Abnormalities

Noninvasive prenatal aneuploidy testing of chromosomes 13, 18, 21, X, and Y, using targeted sequencing of polymorphic loci

Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing.

Selective analysis of cell-free DNA in maternal blood for evaluation of fetal trisomy.

The measurement of maternal adiposity.

Screening for fetal aneuploidies at 11 to 13 weeks.

Noninvasive prenatal detection and selective analysis of cell-free DNA obtained from maternal blood: evaluation for trisomy 21 and trisomy 18.

Clinical application of massively parallel sequencing-based prenatal noninvasive fetal trisomy test for trisomies 21 and 18 in 11,105 pregnancies with mixed risk factors.

DNA sequencing of maternal plasma to identify Down syndrome and other trisomies in multiple gestations.

Non-Invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18.

P304

662-666

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PD.4119

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P577

2013-05-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236104637

http://www.w3.org/2001/XMLSchema#string

P698

23553731

http://www.w3.org/2001/XMLSchema#string